{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:41:23Z","timestamp":1790912483068,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.vaccine.2018.09.018","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T03:30:35Z","timestamp":1540524635000},"page":"7408-7414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Primary care physicians\u2019 experience with zoster vaccine live (ZVL) and awareness and attitudes regarding the new recombinant zoster vaccine (RZV)"],"prefix":"10.1016","volume":"36","author":[{"given":"Laura P.","family":"Hurley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandy A.","family":"Allison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen L.","family":"Dooling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean T.","family":"O'Leary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori A.","family":"Crane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Brtnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda L.","family":"Beaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan C.","family":"Lindley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Kempe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"RR-5","key":"10.1016\/j.vaccine.2018.09.018_b0005","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the advisory committee on immunization practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2018.09.018_b0010","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJMcp1302674","article-title":"Clinical practice: herpes zoster","volume":"369","author":"Cohen","year":"2013","journal-title":"N Engl J Med."},{"issue":"16","key":"10.1016\/j.vaccine.2018.09.018_b0015","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMcp1403062","article-title":"Clinical practice. Postherpetic neuralgia","volume":"371","author":"Johnson","year":"2014","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.vaccine.2018.09.018_b0020","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"issue":"44","key":"10.1016\/j.vaccine.2018.09.018_b0025","first-page":"1528","article-title":"Update on herpes zoster vaccine: licensure for persons aged 50 through 59 years","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"47","key":"10.1016\/j.vaccine.2018.09.018_b0030","doi-asserted-by":"crossref","first-page":"6636","DOI":"10.1016\/j.vaccine.2012.08.070","article-title":"Safety of Zostavax\u2013a cohort study in a managed care organization","volume":"30","author":"Baxter","year":"2012","journal-title":"Vaccine"},{"issue":"25","key":"10.1016\/j.vaccine.2018.09.018_b0035","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1016\/j.vaccine.2010.04.003","article-title":"Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster","volume":"28","author":"Mills","year":"2010","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2018.09.018_b0040","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/infdis\/jit182","article-title":"Safety of zoster vaccine in elderly adults following documented herpes zoster","volume":"208","author":"Morrison","year":"2013","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2018.09.018_b0045","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.4161\/hv.7.11.17982","article-title":"Safety and tolerability of zoster vaccine in adults \u226560 years old","volume":"7","author":"Murray","year":"2011","journal-title":"Human Vacc"},{"issue":"7","key":"10.1016\/j.vaccine.2018.09.018_b0050","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/cir970","article-title":"Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50\u201359 years","volume":"54","author":"Schmader","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2018.09.018_b0055","doi-asserted-by":"crossref","first-page":"545","DOI":"10.7326\/0003-4819-152-9-201005040-00004","article-title":"Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial","volume":"152","author":"Simberkoff","year":"2010","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.vaccine.2018.09.018_b0060","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1365-2796.2011.02474.x","article-title":"Safety of zoster vaccine in adults from a large managed-care cohort: a vaccine safety datalink study","volume":"271","author":"Tseng","year":"2012","journal-title":"J Intern Med"},{"issue":"52","key":"10.1016\/j.vaccine.2018.09.018_b0065","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.1016\/j.vaccine.2017.11.013","article-title":"Herpes zoster vaccine live: a 10year review of post-marketing safety experience","volume":"35","author":"Willis","year":"2017","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2018.09.018_b0070","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/infdis\/jiw047","article-title":"Declining effectiveness of herpes zoster vaccine in adults aged \u226560 years","volume":"213","author":"Tseng","year":"2016","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2018.09.018_b0075","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/cid\/ciu918","article-title":"Long-term persistence of zoster vaccine efficacy","volume":"60","author":"Morrison","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2018.09.018_b0080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11606-016-3844-6","article-title":"Determining the optimal vaccination schedule for herpes zoster: a cost-effectiveness analysis","volume":"32","author":"Le","year":"2017","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.vaccine.2018.09.018_b0085","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jix484","article-title":"Clinical usage of the candidate adjuvanted HZ\/su zoster vaccine: re-vaccination of recipients of live attenuated zoster vaccine and co-administration with a seasonal influenza vaccine","author":"Oxman","year":"2017","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2018.09.018_b0090","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-152-9-201005040-00005","article-title":"Barriers to the use of herpes zoster vaccine","volume":"152","author":"Hurley","year":"2010","journal-title":"Ann Intern Med"},{"issue":"16","key":"10.1016\/j.vaccine.2018.09.018_b0095","first-page":"1576","article-title":"Adjuvanted herpes zoster subunit vaccine in older adults","volume":"373","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.vaccine.2018.09.018_b0100","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2018.09.018_b0105","article-title":"Quality of life impact of a recombinant zoster vaccine in adults \u226550 years of age","author":"Curran","year":"2018","journal-title":"J Gerontol A Biol Sci Med Sci."},{"key":"10.1016\/j.vaccine.2018.09.018_b0110","unstructured":"Gruber FM. BLA approval; 2017. https:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM581750.pdf [accessed 11\/6\/2017]."},{"key":"10.1016\/j.vaccine.2018.09.018_b0115","unstructured":"Kaplan S. C.D.C. Panel recommends a new shingles vaccine; 2017. https:\/\/www.nytimes.com\/2017\/10\/25\/health\/cdc-shingles-vaccine.html [accessed 11\/6\/17]."},{"issue":"4","key":"10.1016\/j.vaccine.2018.09.018_b0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.12927\/hcpol.2013.23377","article-title":"Things are not as bad as they seem: physicians' ability to predict their clinical practice when a new vaccine becomes available","volume":"8","author":"Seewald","year":"2013","journal-title":"Healthc Policy = Politiques de sante"},{"key":"10.1016\/j.vaccine.2018.09.018_b0125","unstructured":"University of Colorado. Vaccine policy collaborative initiative; 2017. http:\/\/www.ucdenver.edu\/academics\/colleges\/medicalschool\/programs\/ACCORDS\/childrensoutcomesreserach\/VaccinePolicyCollaborativeInitiative\/Pages\/default.aspx [accessed October 9, 2017]."},{"key":"10.1016\/j.vaccine.2018.09.018_b0130","unstructured":"Weissman A. In: Hurley L, editor. Question; 2018."},{"key":"10.1016\/j.vaccine.2018.09.018_b0135","unstructured":"Schoof B. In: Hurley L, editor. Question \u2013 AAFP member data; 2018."},{"issue":"1","key":"10.1016\/j.vaccine.2018.09.018_b0140","first-page":"43","article-title":"Sentinel physician networks as a technique for rapid immunization policy surveys","volume":"31","author":"Crane","year":"2008","journal-title":"EvalHealth Prof"},{"key":"10.1016\/j.vaccine.2018.09.018_b0145","unstructured":"Vovici Feedback [computer program]. Melville (NY): Verint Systems Inc; 2015."},{"key":"10.1016\/j.vaccine.2018.09.018_b0150","series-title":"Internet, mail and mixed-mode surveys: the tailored design method","author":"Dillman","year":"2009"},{"issue":"1","key":"10.1016\/j.vaccine.2018.09.018_b0155","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11109-010-9121-1","article-title":"Considering mixed mode surveys for questions in political behavior: using the internet and mail to get quality data at reasonable costs","volume":"33","author":"Atkeson","year":"2011","journal-title":"Polit Behav"},{"issue":"4 Pt 1","key":"10.1016\/j.vaccine.2018.09.018_b0160","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1542\/peds.111.4.e299","article-title":"Comparison of e-mail, fax, and postal surveys of pediatricians","volume":"111","author":"McMahon","year":"2003","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.vaccine.2018.09.018_b0165","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/art.23112","article-title":"The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom","volume":"57","author":"Smitten","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.vaccine.2018.09.018_b0170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.2012.7304","article-title":"Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases","volume":"308","author":"Zhang","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2018.09.018_b0175","unstructured":"Matters TD. The demographics of aging; 2017. http:\/\/transgenerational.org\/aging\/demographics.htm [accessed 11\/6\/2017]."},{"issue":"33","key":"10.1016\/j.vaccine.2018.09.018_b0180","first-page":"729","article-title":"Update on recommendations for use of herpes zoster vaccine","volume":"63","author":"Hales","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2018.09.018_b0185","unstructured":"Centers for Disease Control and Prevention. Adult immunization schedule by medical and other indications, recommended immunization schedule for adults aged 19 years or older by medical conditions and other indications, United States; 2017. https:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/imz\/adult-conditions.html [accessed September 20, 2017]."},{"issue":"4","key":"10.1016\/j.vaccine.2018.09.018_b0190","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/hiv.12311","article-title":"Live attenuated herpes zoster vaccine for HIV-infected adults","volume":"17","author":"Shafran","year":"2016","journal-title":"HIV Med"},{"key":"10.1016\/j.vaccine.2018.09.018_b0195","unstructured":"Centers for Disease Control and Prevention. Vaccination coverage among adults in the United States, National Health Interview Survey, 2016; 2018. https:\/\/www.cdc.gov\/vaccines\/imz-managers\/coverage\/adultvaxview\/NHIS-2016.html [accessed April 25, 2018]."},{"issue":"4","key":"10.1016\/j.vaccine.2018.09.018_b0200","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.vaccine.2016.12.007","article-title":"Primary care physicians' perspective on financial issues and adult immunization in the era of the affordable care act","volume":"35","author":"Hurley","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.09.018_b0205","unstructured":"Carr T. Why does my shingles vaccine cost so much? Medicare may not provide good coverage for this vital protection; 2017. https:\/\/www.consumerreports.org\/health\/why-the-shingles-vaccine-cost-so-much\/ [accessed September 29, 2017]."},{"key":"10.1016\/j.vaccine.2018.09.018_b0210","unstructured":"U.S. Government Accountability Office. Medicare: many factors, including administrative challenges, affect access to Part D vaccinations; 2011. http:\/\/www.gao.gov\/products\/GAO-12-61 [accessed February 24, 2016]."},{"key":"10.1016\/j.vaccine.2018.09.018_b0215","unstructured":"Centers for Disease Control and Prevention. Vaccines for children program (VFC); 2017. https:\/\/www.cdc.gov\/vaccines\/programs\/vfc\/awardees\/vaccine-management\/price-list\/index.html [accessed November 6, 2017]."},{"issue":"8","key":"10.1016\/j.vaccine.2018.09.018_b0220","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/infdis\/jiu606","article-title":"Safety and immunogenicity of an adjuvanted herpes zoster subunit candidate vaccine in HIV-infected adults: a phase 1\/2a randomized, placebo-controlled study","volume":"211","author":"Berkowitz","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.09.018_b0225","series-title":"26th European congress of clinical microbiology and infectious diseases (ECCMID)","article-title":"Rates of severe injection-site and systemic adverse events within 7 days postvaccination with ZOSTAVAX\u2122, a post-hoc analysis of two pivotal phase 3 trials","author":"Popmihajlov","year":"2016"},{"key":"10.1016\/j.vaccine.2018.09.018_b0230","unstructured":"Centers for Disease Control and Prevention. Grading of recommendations, assessment, development, and evaluation (GRADE): recombinant zoster vaccine (RZV) and herpes zoster live-attenuated vaccine (ZVL); 2018. https:\/\/www.cdc.gov\/vaccines\/acip\/recs\/grade\/herpes-zoster.html [accessed April 23, 2018]."},{"issue":"1","key":"10.1016\/j.vaccine.2018.09.018_b0235","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1472-6947-12-145","article-title":"Barriers to the use of reminder\/recall interventions for immunizations: a systematic review","volume":"12","author":"Pereira","year":"2012","journal-title":"BMC Med Inform Decis Mak"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18312672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18312672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:30:46Z","timestamp":1759401046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18312672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":47,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0264410X18312672"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary care physicians\u2019 experience with zoster vaccine live (ZVL) and awareness and attitudes regarding the new recombinant zoster vaccine (RZV)","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}